EDITORIAL
Published on 22 Nov 2022
Editorial: Tissue-resident immune cells in tumor immunity and immunotherapy
doi 10.3389/fcell.2022.1068720
- 2,104 views
- 5 citations
- Frontiers in Cell and Developmental Biology
- Molecular and Cellular Pathology
- Research Topics
- Tissue-resident Immune Cells in Tumor Immunity and Immunotherapy
Tissue-resident Immune Cells in Tumor Immunity and Immunotherapy
11k
Total Downloads
39k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 22 Aug 2022
Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor
doi 10.3389/fcell.2022.896147
- 2,105 views
- 3 citations
REVIEW
Published on 11 Aug 2022
Peritoneal resident macrophages in tumor metastasis and immunotherapy
doi 10.3389/fcell.2022.948952
- 4,795 views
- 6 citations
ORIGINAL RESEARCH
Published on 04 Aug 2022
Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
doi 10.3389/fcell.2022.928140
- 2,962 views
- 10 citations
REVIEW
Published on 15 Jul 2022
Fine-tuning of regulatory T cells is indispensable for the metabolic steatosis-related hepatocellular carcinoma: A review
doi 10.3389/fcell.2022.949603
- 2,934 views
- 16 citations
REVIEW
Published on 08 Jul 2022
Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune Responses
doi 10.3389/fcell.2022.933113
- 3,383 views
- 9 citations
REVIEW
Published on 26 May 2022
Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment
doi 10.3389/fcell.2022.907572
- 3,020 views
- 6 citations
REVIEW
Published on 26 May 2022
The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease
doi 10.3389/fcell.2022.896591
- 6,562 views
- 38 citations
OPINION
Published on 04 May 2022
Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling
doi 10.3389/fcell.2022.893709
- 1,097 views
ORIGINAL RESEARCH
Published on 12 Jan 2022
Humanized CD30-Targeted Chimeric Antigen Receptor T Cells Exhibit Potent Preclinical Activity Against Hodgkin’s Lymphoma Cells
doi 10.3389/fcell.2021.775599
- 3,468 views
- 10 citations
Published in
Frontiers in Cell and Developmental Biology
- Molecular and Cellular Pathology
- Cancer Cell Biology
Impact
- 39kTopic views
- 25kArticle views
- 11kArticle downloads